List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 133 studies with search of:   "Daunorubicin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase 3 Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)
Condition: Secondary Acute Myeloid Leukemia (sAML)
Interventions: Drug: Daunorubicin and Cytarabine;   Drug: Amonafide and Cytarabine
2 Completed DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML
Conditions: AML;   Elderly
Interventions: Drug: DaunoXome;   Drug: Daunorubicine
3 Completed Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)
Condition: Leukemia, Myeloid
Interventions: Drug: Zosuquidar;   Drug: Daunorubicin;   Drug: Cytarabine
4 Completed A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Daunorubicin (liposomal);   Drug: Bleomycin sulfate;   Drug: Vincristine sulfate;   Drug: Doxorubicin hydrochloride
5 Completed Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: liposomal daunorubicin citrate;   Drug: semaxanib
6 Recruiting Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: everolimus;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study
7 Active, not recruiting Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: oblimersen
8 Recruiting Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: daunorubicin hydrochloride;   Procedure: cytogenetic analysis;   Procedure: immunologic technique;   Procedure: pharmacological study;   Procedure: protein expression analysis
9 Recruiting Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: midostaurin;   Drug: placebo
10 Recruiting Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: imatinib mesylate
11 Active, not recruiting Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: oblimersen
12 Recruiting Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: bortezomib;   Drug: cytarabine;   Drug: daunorubicin hydrochloride
13 Active, not recruiting Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: filgrastim;   Drug: sargramostim
14 Active, not recruiting PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: midostaurin
15 Active, not recruiting Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.
Condition: Hematologic Neoplasms
Intervention: Drug: CPX-351 (Cytarabine:Daunorubicin) Liposome Injection
16 Recruiting Trial of CPX-351 in Newly Diagnosed Edlerly AML Patients
Condition: Acute Myeloid Leukemia
Interventions: Drug: CPX-351;   Drug: Cytarabine + Daunorubicin - 7 and 3
17 Recruiting Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
Condition: Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: daunorubicin hydrochloride;   Procedure: dual x-ray absorptometry;   Procedure: pharmacological study
18 Active, not recruiting Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: filgrastim;   Drug: sargramostim
19 Recruiting High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
Condition: Acute Myelogenous Leukemia
Intervention: Drug: daunorubicin
20 Active, not recruiting PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: filgrastim;   Drug: sargramostim;   Drug: valspodar

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services